Literature DB >> 8984683

Autoimmune responses in peripheral nerve.

H P Hartung1, H Willison, S Jung, M Pette, K V Toyka, G Giegerich.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8984683     DOI： 10.1007/bf00792612

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  229 in total

1.  Rat and human Schwann cells in vitro can synthesize and express MHC molecules.

Authors:  P J Armati; J D Pollard; P Gatenby
Journal:  Muscle Nerve       Date:  1990-02       Impact factor: 3.217

2.  Detection and quantification of antibodies to the extracellular domain of P0 during experimental allergic neuritis.

Authors:  J J Archelos; K Roggenbuck; J Schneider-Schaulies; K V Toyka; H P Hartung
Journal:  J Neurol Sci       Date:  1993-07       Impact factor: 3.181

3.  Transfer of experimental allergic neuritis with P2-reactive T-cell lines.

Authors:  A Rostami; J B Burns; M J Brown; J Rosen; B Zweiman; R P Lisak; D E Pleasure
Journal:  Cell Immunol       Date:  1985-04-01       Impact factor: 4.868

4.  Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome.

Authors:  H J Willison; J Veitch
Journal:  J Neuroimmunol       Date:  1994-03       Impact factor: 3.478

5.  Effect of reactive oxygen species on myelin membrane proteins.

Authors:  G W Konat; R C Wiggins
Journal:  J Neurochem       Date:  1985-10       Impact factor: 5.372

6.  Gamma interferon, but not Mycobacterium leprae, induces major histocompatibility class II antigens on cultured rat Schwann cells.

Authors:  N M Samuel; K R Jessen; J M Grange; R Mirsky
Journal:  J Neurocytol       Date:  1987-04

7.  An acute axonal form of Guillain-Barré polyneuropathy.

Authors:  T E Feasby; J J Gilbert; W F Brown; C F Bolton; A F Hahn; W F Koopman; D W Zochodne
Journal:  Brain       Date:  1986-12       Impact factor: 13.501

8.  Cloning of human anti-GM1 antibodies from motor neuropathy patients.

Authors:  H J Willison; G Paterson; P G Kennedy; J Veitch
Journal:  Ann Neurol       Date:  1994-04       Impact factor: 10.422

9.  Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin.

Authors:  P Fredman; C A Vedeler; H Nyland; J A Aarli; L Svennerholm
Journal:  J Neurol       Date:  1991-04       Impact factor: 4.849

10.  A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo.

Authors:  C Linington; S Izumo; M Suzuki; K Uyemura; R Meyermann; H Wekerle
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422
View more
  5 in total

1.  Vaccination, prevention, and treatment of experimental autoimmune neuritis (EAN) by an oligomerized T cell epitope.

Authors:  M Stienekemeier; K Falk; O Rötzschke; A Weishaupt; C Schneider; K V Toyka; R Gold; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

Review 2.  The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis.

Authors:  Hong-liang Zhang; Jiang Wu; Jie Zhu
Journal:  J Biomed Biotechnol       Date:  2010-02-16

3.  Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.

Authors:  C S Goodyear; G M O'Hanlon; J J Plomp; E R Wagner; I Morrison; J Veitch; L Cochrane; R W Bullens; P C Molenaar; J Conner; H J Willison
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

4.  Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy.

Authors:  E A Marsh; C L Hirst; J G Llewelyn; M D Cossburn; M M Reilly; A Krishnan; M Doran; A M Ryan; A J Coles; J L Jones; N P Robertson
Journal:  J Neurol       Date:  2010-01-06       Impact factor: 4.849

5.  Expression of RhoA by inflammatory macrophages and T cells in rat experimental autoimmune neuritis.

Authors:  Zhiren Zhang; Uwe Fauser; Hermann J Schluesener
Journal:  J Cell Mol Med       Date:  2007 Jan-Feb       Impact factor: 5.310
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.